NEAR - The October CURSE | Near Coin Price Prediction
1 extracted signal · 0 resolved · 1 still active
Altcoin DoctorIndependent analyst profile- Source published
- 14 Oct 2026, 10:13 UTC
- Recorded by Tahlil Plus
- 14 Oct 2026, 14:11 UTC

AI-generated source summary
The analysis focuses on the NEAR Protocol (NEARUSDT) and its price action on the weekly timeframe. The current price is observed at $5.0374, with an indicated target of $6.8. The analysis suggests a bullish outlook for NEAR, expecting it to break out to higher prices. A failure bound is set at $4.5, below which the bullish thesis would be invalidated. The video also touches upon broader market trends by analyzing the USDT dominance and total crypto market cap excluding BTC and ETH. The USDT dominance is seen to be falling, suggesting a bullish sentiment for altcoins and the overall crypto market. Conversely, the total crypto market cap excluding BTC and ETH is observed to be in a bullish uptrend. This suggests that money is flowing out of stablecoins and into altcoins, indicating a potential altcoin season. The speaker implies that the current downtrend in USDT.D and Bitcoin dominance could lead to a significant upward movement in altcoins.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
1 signal remains active.
Altcoin Doctor
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
